Tafenoquine is an 8-aminoquinoline with activity against all human life cycle stages of
Plasmodium vivax, including dormant liver stages – so called hypnozoites. Its long half-life of ~15 …

Malaria is one of the most life-threatening infectious diseases and constitutes a major health
problem, especially in Africa. Although artemisinin combination therapies remain efficacious …

Introduction: Malaria is a major health problem in endemic countries and chemotherapy
remains the most important tool in combating it. Treatment options are limited and essentially …

The recent demonstration that purified natural killer (NK) cells lyse Plasmodium falciparum–parasitized
red blood cells (Pf-pRBCs) suggests that innate immunity is important in malaria. …

Malaria and cancer cause the death of millions of people every year. To combat these two
diseases, it is important that new pharmaceutically active compounds have the ability to …

Malaria remains one of the major health problems worldwide. The lack of an effective vaccine
and the increasing resistance of Plasmodium to the approved antimalarial drugs demands …

A highly protective malaria vaccine would greatly facilitate the prevention and elimination of
malaria and containment of drug-resistant parasites 1 . A high level (more than 90%) of …

SARS-CoV-2 is evolving with mutations in the receptor binding domain (RBD) being of
particular concern. It is important to know how much cross-protection is offered between strains …

Background Controlled human malaria infection (CHMI) accelerates development of anti-malarial
interventions. So far, CHMI is done by exposure of volunteers to bites of five …

Background A drug for causal (ie, pre-erythrocytic) prophylaxis of Plasmodium falciparum
malaria with prolonged activity would substantially advance malaria control. DSM265 is an …